Horizon Pharma (HZNP) Affirms FY 2016 Net Sales Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to Horizon Pharma (HZNP) Affirms FY 2016 Net Sales Guidance

Brean Capital Cuts Price Target After Horizon Pharma (HZNP) Releases Soft Guidance

April 14, 2016 9:40 AM EDT

Brean Capital maintained a Buy rating on Horizon Pharma (NASDAQ: HZNP), and cut the price target to $30.00 (from $32.00), after the company provided soft 1Q and 2Q guidance. The company now expects to generate 19-20%/22-23%/57-59% of FY16 sales vs. previous consensus estimates of... More

UBS Cuts Price Target on Horizon Pharma (HZNP) After Meeting with Management

April 13, 2016 8:20 AM EDT

UBS maintained a Buy rating on Horizon Pharma (NASDAQ: HZNP), and cut the price target to $24.00 (from $39.00), after meeting with management. Horizon is expecting the 1H16 to be slower than 2H16 as it needs to absorb the deductibles that patients cover before drug... More

Piper Jaffray Remains Bullish on Horizon Pharma (HZNP) as Stock Loses Value

April 13, 2016 7:55 AM EDT

Piper Jaffray maintained an Overweight rating and $44.00 price target on Horizon Pharma (NASDAQ: HZNP) after the stock loses over a quarter of its value following detail from management regarding the cadence of expected quarterly results. Management cited a higher than expected gross-to-net spreads as one driver associated with lower 1Q16 EPS contribution versus other... More